ArticleCancer medicine2023

Evaluation of cardiotoxicity of anthracycline-containing chemotherapy regimens in patients with bone and soft tissue sarcomas: A study of the FDA adverse event reporting system joint single-center real-world experience.

Zeming Mo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.